Jeffrey Tomaszewski

Cooper University Health Care — United States

Medicine · Health Sciences

28h-index1.7kcitations164works0.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(46), Renal cell carcinoma treatment(40), Prostate Cancer Treatment and Research(40), Bladder and Urothelial Cancer Treatments(28), Renal and related cancers(21)

Publications164 total

Renal Paraganglioma: A Rare Case of Secondary Hypertension in a Young Patient
Journal of Urological Surgery·2025Open Access
Investigating the Usage of Abiraterone in African American Men with Metastatic Prostate Cancer
Journal of Racial and Ethnic Health Disparities·2025Open Access
Long-term safety of radium-223 (Ra-223) in metastatic castration-resistant prostate cancer (mCRPC): 7-year follow-up from the largest global prospective study.
Journal of Clinical Oncology·2025
Real-World Management of High-Risk Prostate Cancer Post-Radical Prostatectomy: Insights from a Regional Quality Collaborative
Cancers·2025· 1 citedOpen Access
Ewing Sarcoma Family of Tumors (ESFTs) of Renal Origin Presenting With Bone Metastases: A Case Report
Cureus·2025Open Access
Abstract C160: Baseline characteristics, safety, and efficacy of Radium-223 in metastatic castration resistant prostate cancer by race: Insights from the REASSURE US subset
Cancer Epidemiology Biomarkers & Prevention·2024
Appropriateness of Imaging for Low-Risk Prostate Cancer—Real World Data from the Pennsylvania Urologic Regional Collaboration (PURC)
Current Oncology·2024Open Access
Comparing patient profiles and treatment outcomes with radium-223 (<sup>223</sup>Ra) in real-world settings: Academic vs. community practice in the US—Insights from the REASSURE study.
Journal of Clinical Oncology·2024
MP02-18 APPROPRIATENESS OF IMAGING FOR LOW-RISK PROSTATE CANCER – REAL WORLD DATA FROM THE PENNSYLVANIA UROLOGIC REGIONAL COLLABORATION (PURC)
The Journal of Urology·2024
Safety and effectiveness of the radium‐223–taxane treatment sequence in patients with metastatic castration‐resistant prostate cancer in a global observational study (REASSURE)
Cancer·2024· 9 citedOpen Access
Safety outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223 following external beam radiation therapy: REASSURE US subset.
Journal of Clinical Oncology·2024
Model risk scores may underestimate rate of biochemical recurrence in African American men with localized prostate cancer: a cohort analysis of over 3000 men
Prostate Cancer and Prostatic Diseases·2023· 5 cited
Multiparametric MRI is not sufficient for prostate cancer staging: A single institutional experience validated by a multi-institutional regional collaborative
Urologic Oncology Seminars and Original Investigations·2023· 8 citedOpen Access
Real-world safety and effectiveness of radium-223 (<sup>223</sup>Ra) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated in the US: The non-interventional REASSURE study.
Journal of Clinical Oncology·2023
Paratesticular leiomyosarcoma with metastasis to the extremities and lungs
Radiology Case Reports·2022· 3 citedOpen Access
Utility of PSA density in patients with PI-RADS 3 lesions across a large multi-institutional collaborative
Urologic Oncology Seminars and Original Investigations·2022· 28 cited
Model Risk Scores May Underestimate Rate of Biochemical Recurrence in African American Men with Localized Prostate Cancer: A Cohort Analysis of Over 3000 Men
Research Square (Research Square)·2022Open Access
Non-infectious complications following transrectal prostate needle biopsy – Outcomes from over 8000 procedures
Prostate International·2022· 6 citedOpen Access
PD41-05 BIOPSY TECHNIQUE (TRANSPERINEAL VS. TRANSRECTAL) IS NOT ASSOCIATED WITH POSITIVE SURGICAL MARGINS OR PERIOPERATIVE MORBIDITY FOLLOWING RADICAL PROSTATECTOMY
The Journal of Urology·2022
MP43-16 RACIAL DISPARITIES IN RATES OF GLEASON GRADE RECLASSIFICATION IN A MULTI-INSTITUTIONAL PROSTATE CANCER ACTIVE SURVEILLANCE COHORT: A PENNSYLVANIA UROLOGY REGIONAL COLLABORATIVE (PURC) ANALYSIS
The Journal of Urology·2022
page 1 of 9Next →

Frequent Co-authors

Marc C. Smaldone(20), Robert G. Uzzo(20), Alexander Kutikov(19), Reza Mehrazin(13), David Y.T. Chen(10), Daniel Canter(8), Rosalia Viterbo(8), Serge Ginzburg(8), Richard E. Greenberg(7), Stephen V. Jackman(6), Michael C. Ost(6), Philip H. Abbosh(5), Timothy Ito(5), Marc C. Smaldone(5), Anthony Corcoran(4), Tianyu Li(4), Timothy D. Averch(4), Anthony T. Corcoran(4), Joel B. Nelson(4), Benjamin T. Ristau(4)